while in the promptly evolving field of cancer therapeutics, knowing the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is very important for creating powerful therapies. Probably the most promising approaches is using in vitro bystander result assays, which Enjoy a pivotal function in improving therapeutic efficacy. These assays, supplied